wilrobinsun

Epix Surrenders Battle to Keep Alzheimer's Program Afloat

I made a nice profitable trade in EPIX, but I have no position now. But I must comment on this "article." How is this nothing more than a restatement of the company's website? Where is the analytical value? What is the author's contribution, the headline?

If the author is a co-founder of BioMedReports, can I expect a higher standard?

Epix Surrenders Battle to Keep Alzheimer's Program Afloat

I made a nice profitable trade in EPIX, but I have no position now. But I must comment on this "article." How is this nothing more than a restatement of the company's website www.epixpharma.com/ ? Where is the analytical value? What is the author's contribution, the headline?

If the author is a co-founder of BioMedReports, can I expect a higher standard?

Hank Paulson: A Rare Keeper

Looks like there was a grave mistake in your article, you used the word "Keeper" in place of "Criminal?"

IncrediMail Gets A Stay Of Execution From Google

Click-fraud is a possibility, but I don't think it is reasonable to refer to it as "a safe bet."

I discount the idea of click fraud for two reasons; 1) if it were systemic Google would have detected it and acted on it earlier, 2) forgiveness would not have been offered so quickly.

There are a number of different ways to run afoul of Google and I suspect that MAIL stepped over some invisible line, probably while implementing their recent search optimization initiative.

Disclosure: I traded the bounce, but I have no position now.